Sirio Pharma and Best Formulations announce US gummy manufacturing capabilities
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Animations, colors, and shapes help to improve poor situational awareness, which is responsible for 81.5% of anesthesia-related errors
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Subscribe To Our Newsletter & Stay Updated